计算溶液所需的质量、体积或浓度。
Moligand™ 级 ,适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
SSTC3 is a casein kinase 1α (CK1α) activator ( K d = 32 nM) that inhibits WNT signaling ( EC 50 = 30 nM). SSTC3 exhibits minimal gastrointestinal toxicity compared to other classes of WNT inhibitors.
In Vitro
SSTC3 (0-1μM, 5 days) decreases the viability of HCT116 cells in an on-target manner. This capacity is significantly reduced when the mutant CTNNB1 allele driving its carcinogenic properties is deleted. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: Colorectal cancer (CRC) cell lines. Concentration: 0-1 μM. Incubation Time: 5 days. Result: Decreased the viability. Western Blot AnalysisCell Line: SW403 cells. Concentration: 100 nM. Incubation Time: 15 min. Result: Increased β-catenin phosphate levels.
In Vivo
SSTC3 can be maintained for 24 hours after treatment . SSTC3 (25 mg/kg, ip once daily for 8-12 days) suppresses the growth of colorectal carcinoma in CD-1 mice . SSTC3 (10 mg/kg, ip once daily for 1 month) inhibits the growth of Apc mutation-driven tumors . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Five-week-old Apc min mice . Dosage: 10 mg/kg. Administration: IP for 1 month. Result: Inhibited the growth of Apc mutation-driven tumors. Animal Model: CD-1 mice. Dosage: 25 mg/kg. Administration: IP once daily for 8-12 days. Result: Inhibited the growth of HCT116 xenografts. Attenuated the growth of this metastatic CRC PDX and markedly reduced the cell density of residual cancer. Reduced the expression of WNT biomarkers in this CRC PDX.